Open access
Open access
Powered by Google Translator Translator

Archives

Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19

20 May, 2020 | 09:50h | UTC

ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis – Pharmacological Research

Related Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv

 


Meta-Analysis: Accuracy of Chest CT for detecting COVID-19

20 May, 2020 | 09:49h | UTC

Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy – European Radiology

 


Meta-Analysis: Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment

20 May, 2020 | 09:45h | UTC

Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis – JAMA (free for a limited period)

Commentary: Controlling blood pressure may reduce dementia risk by 7% – UPI

 


Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU

20 May, 2020 | 09:46h | UTC

Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists – Pediatric Critical Care Medicine

Related: Repurposing a Pediatric ICU for Adults – New England Journal of Medicine

 


Meta-analysis: Utility of Broad-spectrum Antibiotics for Diagnosing Pulmonary Tuberculosis in Adults

20 May, 2020 | 09:44h | UTC

Utility of broad-spectrum antibiotics for diagnosing pulmonary tuberculosis in adults: a systematic review and meta-analysis – The Lancet Infectious Diseases

Commentary: The uncertainty of tuberculosis diagnosis – The Lancet Infectious Diseases

 


Should Azithromycin be Used to Treat COVID-19?

20 May, 2020 | 09:47h | UTC

Should azithromycin be used to treat COVID-19? A rapid review – BJGP Open

 


Wed May 20 – 10 Stories of The Day!

20 May, 2020 | 10:03h | UTC

 

1 – Editorial: Lack of efficacy of hydroxychloroquine in covid-19 – The BMJ

Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ

Related Meta-analysis (preprint): Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv

 

2 – Covid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg

See also: People who recover from coronavirus and test positive again are NOT contagious: Korean CDC finds ‘re-positive’ patients did not infect any of their 790 contacts – Daily Mail

 

3 – Keep your nose out of it: why saliva tests could offer a better alternative to nasal COVID-19 swabs – The Conversation

Original Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics

Related Study: Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease-2019 (COVID-19): a cross-sectional study – Clinical Microbiology and Infection

 

4 – Reducing the Risk of Diagnostic Error in the COVID-19 Era – Journal of Hospital Medicine

 

5 – Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study – The Lancet

Commentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI

 

6 – Personal Protective Equipment and Covid-19 – New England Journal of Medicine

 

7 – The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction – New England Journal of Medicine

Related Study: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine

 

8 – Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward – Science Immunology

 

9 – Why do some COVID-19 patients infect many others, whereas most don’t spread the virus at all? – Science

 

10 –COVID-19 Updates / 20 May 2020 Edition

20 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Management of Acute Kidney Injury in Patients with COVID-19

19 May, 2020 | 04:40h | UTC

Management of acute kidney injury in patients with COVID-19 – The Lancet Respiratory Medicine

Related: Acute Kidney Injury In Patients Hospitalized With Covid-19 – Kidney International

 


Covid-19 Case Series: Acute Heart Failure in Multisystem Inflammatory Syndrome in Children

19 May, 2020 | 04:37h | UTC

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic – Circulation

Related Case Report: Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19 – The Lancet Child & Adolescent Health

 

Related Commentary on Twitter

 


Meta-Analysis: Psychiatric and Neuropsychiatric Presentations Associated with Severe Coronavirus Infections

19 May, 2020 | 04:39h | UTC

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic – The Lancet Psychiatry

 


Viewpoint: Accelerating COVID-19 Therapeutic Interventions and Vaccines

19 May, 2020 | 04:31h | UTC

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times – JAMA

Commentary: NIH Director: Defeating COVID-19 requires unprecedented action and collaboration – National Institutes of Health

Related Viewpoint: Planning for a COVID-19 Vaccination Program – JAMA

 


Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California

19 May, 2020 | 04:34h | UTC

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 – JAMA

“the prevalence of antibodies to SARS-CoV-2 was 4.65%. The estimate implies that approximately 367 000 adults had SARS-CoV-2 antibodies, which is substantially greater than the 8430 cumulative number of confirmed infections in the county on April 10”

 


Cross-neutralization of SARS-CoV-2 by a Human Monoclonal SARS-CoV Antibody

19 May, 2020 | 04:35h | UTC

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody – Nature

Commentary: Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody – News Medical

 


[No Publication Available] Hamster Research Shows Effectiveness of Masks ‘Huge’ in Covid-19 Battle

19 May, 2020 | 04:30h | UTC

Coronavirus: hamster research shows effectiveness of masks ‘huge’ in Covid-19 battle, Hong Kong scientists say – South China Morning Post

 


Decline in Child Vaccination Coverage During the COVID-19 Pandemic

19 May, 2020 | 04:26h | UTC

Decline in Child Vaccination Coverage During the COVID-19 Pandemic — Michigan Care Improvement Registry, May 2016–May 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: More evidence US childhood vaccinations are dropping amid coronavirus pandemic – CNN AND Michigan reports a sharp drop in child vaccinations after the CDC warned missed shots could lead to a measles resurgence across the US – Business Insider

 


SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany

19 May, 2020 | 04:22h | UTC

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany – CDC Emerging Infectious Diseases

 


Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19

19 May, 2020 | 04:24h | UTC

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19 – CDC Emerging Infectious Diseases

 


Early Data Show Moderna Covid-19 Vaccine Generates Immune Response

19 May, 2020 | 04:29h | UTC

Early data show Moderna Covid-19 vaccine generates immune response – STAT

See also: Moderna Coronavirus Vaccine Trial Shows Promising Early Results – The New York Times AND Expert reaction to Moderna announcement about their phase 1 trial data on their mRNA vaccine (mRNA-1273) candidate against COVID-19 – Science Media Centre

 


Infection of Dogs with SARS-CoV-2

19 May, 2020 | 04:19h | UTC

Infection of dogs with SARS-CoV-2 -Nature

Commentary: Coronavirus in cats and dogs: How does COVID-19 impact pets? – CNet

 


Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology

19 May, 2020 | 04:20h | UTC

Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology – American Journal of Respiratory and Critical Care Medicine

 


Cardiac Surgery during the COVID‐19 Pandemic

19 May, 2020 | 04:17h | UTC

Cardiac Surgery during the COVID‐19 Pandemic: Perioperative Considerations and Triage Recommendations – Journal of the American Heart Association

 


Resuming Elective Orthopedic Surgery During the COVID-19 Pandemic

19 May, 2020 | 04:15h | UTC

Resuming Elective Orthopaedic Surgery During the COVID-19 Pandemic: Guidelines Developed by the International Consensus Group (ICM) – Journal of Bone & Joint Surgery

 


COVID-19 Implications for Perioperative and Critical Care Physicians

19 May, 2020 | 04:18h | UTC

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians – Anesthesiology

 


Open-access Science Funders Announce Price Transparency Rules for Publishers

19 May, 2020 | 04:12h | UTC

Open-access science funders announce price transparency rules for publishers – Science

Original Guidance: Plan S Price Transparency Frameworks: guidance & requirements – Plan S

News Release: cOAlition S announces price transparency requirements – Plan S

Related: Plan S: Making Full and Immediate Open Access a Reality AND UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject) AND PLOS and the University of California announce open access publishing agreement – PLOS Blogs AND The war to free science – Vox (free) AND WHO Joins Coalition for Free Digital Access to Health Research

 


Shifting the Paradigm: Using Disease Outbreaks to Build Resilient Health Systems

19 May, 2020 | 04:13h | UTC

Shifting the paradigm: using disease outbreaks to build resilient health systems – BMJ Global Health

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.